...BRCA2 and CDKN1A interacting protein implicated in HR and inhibition of DNA replication stress. In this study, we determ...
...BRCA2 or ATM. Moreover, like earlier generation PARP inhibitors, olaparib and veliparib sensitized cells to the topoisom...
...BRCA2 confer an increased risk of cancer development, at least in part because the BRCA2 protein is required for the mai...
...BRCA2 genes have a significant risk of developing breast and ovarian cancer over the course of their lifetime. As a resu...
...BRCA2 Asn³⁷²His. Gene-environment interactions were assessed using MDR analysis. The overall best model by MDR was tobac...
...BRCA2 been clearly defined. However, it is clear that defects in HR and other DNA repair pathways are important to the e...
...BRCA2. A recent article suggested that BRCA2-related EOC was associated with an improved prognosis, but the effect of BR...
In the past, hereditary ovarian carcinoma was attributed almost entirely to mutations in BRCA1 and BRCA2, with a much sm...
...BRCA2 mutations. Histopathology, germline and somatic BRCA1 or BRCA2 mutations, BRCA1 methylation, and BRCA1 and BRCA2 m...
...BRCA2 (15-30%). The deletion or mutation of TP53 results in a dysregulated inflammatory signal network and contributes t...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2026.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
